Journal article · 2026 · Open access

Accelerating scientific discovery with Co-Scientist

Juraj Gottweis, Wei‐Hung Weng, Alexander Daryin, Tao Tu, Petar Sirkovic, Anatoly Myaskovsky, Grzegorz Glowaty, Felix Weissenberger, Alessio Orlandi, Dan Popovici, Anil K. Palepu, Keran Rong and 39 more

Nature, 655(8122), 487–496 · Published 19 May 2026 · DOI 10.1038/s41586-026-10644-y

Free PDFView at the publisherCite this paper

In brief

“Accelerating scientific discovery with Co-Scientist” is a 2026 journal article by Juraj Gottweis and 50 co-authors, published in Nature. OpenAlex counts 1,012 citations as of 15 November 2026, which puts it in the top 5% of works published in 2026 by citations. It is open access: the full text is free to read at Nature.

Citations
1,012
Most cited in
2026 (776)
Field-weighted impact
1219.44
References
58
Authors
51

Abstract

Scientific discovery is driven by scientists generating hypotheses for complex problems that undergo rigorous experimental validation. To augment this process, we introduce Co-Scientist, a multi-agent artificial intelligence (AI) system built on Gemini for structured scientific thinking and hypothesis generation. Co-Scientist aims to help scientists discover new original knowledge. Conditioned on their research objectives and previous scientific evidence, it formulates demonstrably novel research hypotheses for experimental verification. The system’s design involves agents continuously generating, critiquing and refining hypotheses accelerated by scaling test-time compute. Key contributions include (1) a multi-agent architecture with an asynchronous task execution framework for flexible compute scaling, and (2) a tournament evolution process for self-improving hypotheses generation. Automated evaluations show continued benefits of test-time compute scaling, improving hypothesis quality over time. Although this is a general-purpose system, we focus the validation in three biomedical applications: drug repurposing; novel-target discovery 1 ; and explaining mechanisms of antimicrobial resistance 2 . Specifically, Co-Scientist helped to identify new drug-repurposing candidates and synergistic combination therapies for acute myeloid leukaemia that were validated through in vitro experiments. These real-world validations demonstrate the potential of Co-Scientist to accelerate scientific discovery and usher in an era of AI-empowered scientists.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gottweis, J., Weng, W., Daryin, A., Tu, T., Sirkovic, P., Myaskovsky, A., Glowaty, G., Weissenberger, F., Orlandi, A., Popovici, D., Palepu, A. K., Rong, K., Tanno, R., Saab, K. K., Zhang, F., Blum, J. A., Carroll, A. W., Kulkarni, K., Tomašev, N., . . . Natarajan, V. (2026). Accelerating scientific discovery with Co-Scientist. Nature, 655(8122), 487–496. https://doi.org/10.1038/s41586-026-10644-y

MLA 9

Gottweis, Juraj, et al. “Accelerating scientific discovery with Co-Scientist.” Nature, vol. 655, no. 8122, 2026, pp. 487–496. https://doi.org/10.1038/s41586-026-10644-y.

Chicago

Gottweis, Juraj, Wei‐Hung Weng, Alexander Daryin, Tao Tu, Petar Sirkovic, Anatoly Myaskovsky, Grzegorz Glowaty, et al. 2026. “Accelerating scientific discovery with Co-Scientist.” Nature 655 (8122): 487–496. https://doi.org/10.1038/s41586-026-10644-y.

Harvard

Gottweis, J. et al. (2026) ‘Accelerating scientific discovery with Co-Scientist’, Nature, 655(8122), pp. 487–496. doi:10.1038/s41586-026-10644-y.

IEEE

J. Gottweis et al., “Accelerating scientific discovery with Co-Scientist,” Nature, vol. 655, no. 8122, pp. 487–496, 2026, doi: 10.1038/s41586-026-10644-y.

BibTeX

@article{gottweis2026accelerating,
  title     = {{Accelerating scientific discovery with Co-Scientist}},
  author    = {Gottweis, Juraj and Weng, Wei‐Hung and Daryin, Alexander and Tu, Tao and Sirkovic, Petar and Myaskovsky, Anatoly and Glowaty, Grzegorz and Weissenberger, Felix and Orlandi, Alessio and Popovici, Dan and Palepu, Anil K. and Rong, Keran and Tanno, Ryutaro and Saab, Khaled Kamal and Zhang, Fan and Blum, Jacob A. and Carroll, Andrew W. and Kulkarni, Kavita and Tomašev, Nenad and Zverinski, Dina and Rendulic, Ivor and Vedadi, Elahe and Hasler, Florian and Rimanić, Luka and Boia, Marina and Budiselic, Ivan and Feinstein, Ben and Bellaiche, Mathias and Sheffer, Tom and Freyberg, Jan and others},
  journal   = {Nature},
  year      = {2026},
  volume    = {655},
  number    = {8122},
  pages     = {487--496},
  doi       = {10.1038/s41586-026-10644-y},
  url       = {https://doi.org/10.1038/s41586-026-10644-y}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202433
2025233233
2026776776

Its field-weighted citation impact is 1219.44: it has been cited 1219.44 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • multi-agent systems
  • hypothesis generation
  • scientific discovery
  • Gemini
  • test-time compute scaling
  • asynchronous task execution
  • drug repurposing
  • antibiotic resistance mechanisms

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Gottweis, J., Weng, W., Daryin, A., Tu, T., Sirkovic, P., Myaskovsky, A., Glowaty, G., Weissenberger, F., Orlandi, A., Popovici, D., Palepu, A. K., Rong, K., Tanno, R., Saab, K. K., Zhang, F., Blum, J. A., Carroll, A. W., Kulkarni, K., Tomašev, N., . . . Natarajan, V. (2026). Accelerating scientific discovery with Co-Scientist. Nature, 655(8122), 487–496. https://doi.org/10.1038/s41586-026-10644-y

How many times has this paper been cited?

1,012 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Nature.

Who wrote this paper?

Juraj Gottweis, Wei‐Hung Weng, Alexander Daryin, Tao Tu, Petar Sirkovic, Anatoly Myaskovsky, Grzegorz Glowaty, Felix Weissenberger, Alessio Orlandi, Dan Popovici, Anil K. Palepu, Keran Rong and 39 more.

What is the DOI of this paper?

10.1038/s41586-026-10644-y. The permanent link is https://doi.org/10.1038/s41586-026-10644-y.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.